Sign In to Follow Application
View All Documents & Correspondence

A Cosmetic Product For Imparting A Glow Or Sunless Tan To Skin

Abstract: A cosmetic composition for sunless tanning or imparting glow to skin is herein described. The composition includes from 0.1 to 20% by weight of a tanning agent and from 0.1 to 20% by weight of a crosslinked cationic copolymer having a monomer unit which is a methacryloylethyl or acryloylethyl tri(C1-C3 alkyl)ammonium salt. The crosslinked cationic copolymer is a colour enhancing agent which improves colour intensity and avoids streaking of the developing tan/glow.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
18 August 2010
Publication Number
40/2011
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Patent Number
Legal Status
Grant Date
2016-05-20
Renewal Date

Applicants

HINDUSTAN UNILEVER LIMITED
HINDUSTAN LEVER HOUSE, 165-166 BACKBAY RECLAMATION, MUMBAI, 400 020, INDIA

Inventors

1. POLONKA JACK
UNILEVER HOME & PERSONAL CARE USA, 40 MERRITT BOULEVARD, TRUMBULL, CONNECTICUT 06611, UNITED STATES OF AMERICA
2. BARTOLONE JOHN BRIAN
UNILEVER HOME & PERSONAL CARE USA, 40 MERRITT BOULEVARD, TRUMBULL, CONNECTICUT 06611, UNITED STATES OF AMERICA

Specification

FORM - 2
THE PATENTS ACT, 1970
(39 of 1970)
&
The Patents Rules, 2003
COMPLETE SPECIFICATION
(See Section 10 and Rule 13)
GLOW AND SUNLESS TANNING COLOUR ENHANCEMENT BY CATIONIC
COPOLYMERS
HINDUSTAN UNILEVER LIMITED,
a company incorporated under
the Indian Companies Act, 1913 and having its registered office
at 165/166, Backbay Reclamation, Mumbai -400 020, Maharashtra, India
The following specification particularly describes the invention and the manner in which it is to be performed

GLOW AND SUNLESS TANNING COLOUR ENHANCEMENT BY CATIONIC COPOLYMERS
BACKGROUND OF THE INVENTION
The invention concerns a product for imparting glow and/or a sunless tan to skin. The product includes besides a skin tanning agent also a colour enhancement agent for reducing the time to full maturation and deeper colour intensity.
Today there is a great health concern with natural tanning through sunlight. Ultraviolet radiation from the sun is considered to be a leading factor in causing skin cancer. Even if not lethal, ultraviolet radiation has been acknowledged as accelerating aging and wrinkling processes on the skin.
Beyond health concerns, there are obvious practical reasons against natural tanning. Foremost is the reason that in many areas of the globe and during all but summertime, there is insufficient sunlight available to accomplish the task.
While some choose artificial sunlight as an alternative to exposure to natural sunlight, and as a potentially less risky means of obtaining a tan, this option too. is not always suitable; hence, other options for skin tanning are desirable. One of these options, to which people are turning in increasing numbers, are the various "sunless tanning compositions" that can be used to brown human skin without the necessity of exposing the skin to natural, or artificial, sunlight. Such compositions contain, as their active agent, one or more of the available self tanning agents, including dihydroxyacetone ("DHA," 1,3-d ihydroxy-2-propa none).
DHA, currently the most widely used of the self tanning agents, is believed to exert its effect through interactions between its hydroxyl groups and the amino groups of amino acids and peptides naturally occurring in the hydrolipid pellicle and first layers of the stratum corneum of the skin. Such Mailiard reactions are believed (see, e.g., Bobin et al., J. Soc. Cosmet. Chem. 35: 255 (1984)) to lead to formation of brown pigments in the skin, thereby giving it an appearance similar to that of a naturally obtained tan.

-2-
Although there has been great progress in sunless self-tanning as noted above, considerable further progress is needed to increase speed of colouration and achieve a colouration even closer to a natural look. Furthermore, many of the known self-tanning compositions have poor substantivity. Rub-off onto clothing may occur and thereby impart a stain to the textiles. Many of the formulas are subject to wash-off and sweat-off after their application. There is a need to improve substantivity on the skin. Streaking is also a problem faced by the art. By the term "streaking" is meant non-even deposition on the skin; the colouration tends to migrate along an outer perimeter as a result of the formula being rubbed around upon the skin.
New approaches are required to address one or more of the problems with self-tanning compositions. Thus, the present invention is directed to a product which imparts a more intense (darker) colour not achievable with traditional sunless tanning agents.
SUMMARY OF THE INVENTION
A cosmetic product for imparting a glow or sunless tan to skin is provided which
includes:
(i) from 0.1 to 20% by weight of a tanning agent which is reactive with skin to produce a tan colour;
(ii) from 0.1 to 20% by weight of a colour enhancing agent which is a crosslinked cationic copolymer having monomer units of methacryloylethyl tri(C1-C3 alkyl) ammonium salt or acryloylethyl tri(1-C3 alkyl) ammonium salt; and
(iii) a cosmetically acceptable carrier.
DETAILED DESCRIPTION OF THE INVENTION
Now it has been found that crosslinked cationic copolymers partially formed from monomer units of methacryloylethyl or acryloylethyl tri(C1-C3 alkyl) ammonium salts are effective colour enhancing agents in imparting glow (radiance) and/or sunless tan to skin. The combination of a tanning agent and the cationic copolymer deliver a more intense colour to the treated area of skin. Further, substantivity is enhanced. There is resistance to the tanning agent being washed-off or sweated off. Physically it is also more difficult to rub-off the compositions onto clothing.

-3-
Tanning agents of the present invention are materials which when applied to human skin will react with amino acids of the skin so as to form pigmented species (i.e. a tan). These reactions give skin a brown appearance similar to a colour obtained by exposure to sunlight. These materials may be alpha-hydroxyaldehydes and ketones, glyceraldehyde, troxerutin and related alcohol aldehydes, various indoles, imidazoles and derivatives thereof. Illustrative but not limiting are dihydroxyacetone, melanin, mahakanni (eclipta alba), methyl glyoxal, erythrulose, alloxan, 2,3-dihydroxysuccindialdehyde and mixtures thereof. More preferred is dihydroxyacetone.
Amounts of the tanning agent may range from 0.1 to 20%, preferably from 0.5 to 10%, more preferably from 0.8 to 5%, and optimally from 1 to 2% by weight of the cosmetic composition.
Formulations intended for imparting glow (synonymous with radiance), utilize tanning agent at lower levels such as from 0.5 to 2.5% by weight of the composition. Sunless tanning to a relatively dark shade ordinarily requires the tanning agent to be at the higher levels from 3 to 20% by weight of the composition.
Cationic copolymers of the present invention incorporate as one of the repeating units a methacryloylethyl tri(Ci-C3 alkyl) ammonium salt or an acryloylethyl tri(Ci-C3 alkyl) ammonium salt. The term "salt" for this monomer unit may be but is not limited to chloride, bromide, sulfate, sulphonate, methosulfate, nitrate, tosylate, phosphate and phosphonate. The term "copolymer" means at least two different monomer repeating units, preferably three or more different monomer repeating units. Monomer units that crosslink are particularly useful.
Monomers forming the copolymer with the methacryloylethyl tri(C1-C3 alkyl) ammonium salt or acryloylethyl tri(C1-C3 alkyl) ammonium salt monomer units include: styrene, acrylic acid, methacrylic acid, vinyl chloride, vinyl acetate, vinyl pyrrolidone, isoprene, vinyl alcohol, vinyl methylether, chloro-styrene, dialkylamino-styrene, maleic acid, acrylamide, methacrylamide, tris(hydroxymethyl)-acrylamidomethane and mixtures thereof. Where the term "acid" appears, the term means not only the free acid but also C1-C3 alkyl esters, anhydrides and salts thereof. Preferably but not exclusively the salts thereof may

~4-
be ammonium, alkanolammonium, alkali metal and alkaline earth metal salts. Most preferred are the ammonium and alkanolammonium salts of acid monomers.
Most preferred for purposes of this invention as the cationic copolymer is
acrylamide/acryloylethyl trimethylammonium chloride/tris(hydroxymethyl)-
acrylamidomethane copolymer. Commercial availability is under the trademark 7688 MP available from Seppic Inc.
Number average molecular weight of the copolymers according to the invention may range from 1,000 to 3,000,000, preferably from 3,000 to 100,000, optimally from 10,000 to 80,000.
Amounts of the copolymer may range from 0.1 to 20%, preferably from 0.5 to 10%, more preferably from 1 to 7%, and optimally from 1.5 to 5% by weight of the composition.
Additional enhancement of tanning effect and elimination of streaking can be achieved by utilization of a monomeric quaternary ammonium salt. Particularly useful are C12-C22 fatty alkyl substituted ammonium salts. These may be mono- fatty alkyl or di- fatty alkyl substituted ammonium compounds. Amounts may range from 0.01 to 5%, preferably from 0.05 to 3%, and optimally from 0.15 to 1% by weight of the cosmetic compositions. An illustrative material is distearyf dimethyl ammonium salts, and in particular distearyl dimonium chloride sold under the trademark Varisoft TA-100.
Compositions of this invention will also include a cosmetically acceptable carrier. Amounts of the carrier may range from 1 to 99.9%, preferably from 70 to 95%, optimally from 80 to 90% by weight of the composition. Among the useful carriers are water, emollients, fatty acids, fatty alcohols, thickeners and combinations thereof. The carrier may be aqueous, anhydrous or an emulsion. Preferably the compositions are aqueous, especially water and oil emulsions of the W/O or CVW or triplex W/O/W variety. Water when present may be in amounts ranging from 5 to 95%, preferably from 20 to 70%, optimally from 35 to 60% by weight of the composition.

-5-
Emollient materials may serve as cosmetically acceptable carriers. These may be in the form of silicone oils, natural or synthetic esters and hydrocarbons. Amounts of the emollients may range anywhere from 0.1 to 95%, preferably between 1 and 50% by weight of the composition.
Silicone oils may be divided into the volatile and non-volatile variety. The term "volatile" as used herein refers to those materials which have a measurable vapor pressure at ambient temperature. Volatile silicone oils are preferably chosen from cyclic (cyclomethicone) or linear polydimethylsiloxanes containing from 3 to 9, preferably from 4 to 5, silicon atoms.
Non-volatile silicone oils useful as an emollient material include polyalkyl siloxanes, polyalkylaryl siloxanes and polyether siloxane copolymers. The essentially nonvolatile polyalkyl siloxanes useful herein include, for example, polydimethyl siloxanes with viscosities of from 5 x 10"6 to 0.1 m2/s at 25°C. Among the preferred nonvolatile emollients useful in the present compositions are the polydimethyl siloxanes having viscosities from 1 x 10"5 to 4 x 10"4 m2/s at 25°C.
Another class of non-volatile silicones are emulsifying and non-emulsifying silicone elastomers. Representative of this category is dimethicone/vinyl dimethicone crosspolymer available as Dow Corning 9040, General Electric SFE 839, and Shin-Etsu KSG-18. Silicone waxes such as Silwax W5-L (dimethicone copolyol laurate) may also be useful.
Among the ester emollients are:
a) Alkyl esters of saturated fatty acids having 10 to 24 carbon atoms. Examples thereof include behenyl neopentanoate, isononyl isonanonoate, isopropyl myristate and octyl stearate.
b) Ether-esters such as fatty acid esters of ethoxylated saturated fatty alcohols.
c) Polyhydric alcohol esters. Ethylene glycol mono- and di-fatty acid esters, diethylene glycol mono- and di-fatty acid esters, polyethylene glycol (200-6000) mono- and di-fatty acid esters, propylene glycol mono- and di-fatty acid esters, polypropylene glycol 2000 monostearate, ethoxylated propylene glycol monostearate, glyceryl mono- and

-6-
di-fatty acid esters, polyglycerol poly-fatty esters, ethoxylated glyceryl mono-stearate, 1,3-butylene glycol monostearate, 1,3-butylene glycol distearate, polyoxyethylene polyol fatty acid ester, sorbitan fatty acid esters, and polyoxyethylene sorbitan fatty acid esters are satisfactory polyhydric alcohol esters. Particularly useful are pentaerythritol, trimethylolpropane and neopentyl glycol esters of C1-C30 alcohols.
d) Wax esters such as beeswax, spermaceti wax and tribehenin wax.
e) Sugar ester of fatty acids such as sucrose polybehenate and sucrose polycottonseedate.
Natural ester emollients principally are based upon mono-, di- and tri- glycerides. Representative glycerides include sunflower seed oil, cottonseed oil, borage oil, borage seed oil, primrose oil, castor and hydrogenated castor oils, rice bran oil, soybean oil, olive oil, safflower oil, shea butter, jojoba oil and combinations thereof. Animal derived emollients are represented by lanolin oil and lanolin derivatives. Amounts of the natural esters may range from 0.1 to 20% by weight of the compositions.
Hydrocarbons which are suitable cosmetically acceptable carriers include petrolatum, mineral oil, C11-C13 isoparaffins, polybutenes, and especially isohexadecane, available commercially as Permethyl 101A from Presperse Inc.
Fatty acids having from 10 to 30 carbon atoms may also be suitable as cosmetically acceptable carriers. Illustrative of this category are pelargonic, lauric, myristic, palmitic, stearic, isostearic, oleic, linoleic, linolenic, hydroxy stearic and behenic acids.
Fatty alcohols having from 10 to 30 carbon atoms are another useful category of cosmetically acceptable carrier. Illustrative of this category are stearyl alcohol, laury! alcohol, myristyl alcohol, oleyl alcohol and cetyl alcohol.
Thickeners can be utilized as part of the cosmetically acceptable carrier of compositions according to the present invention. Typical thickeners include crosslinked acrylates (e.g. Carbopol 982®), hydrophobically-modified acrylates (e.g. Carbopol 1382®), polyacrylamides (e.g. Sepigel 305®), acryloylmethylpropane sulfonic acid/salt polymers and copolymers (e.g. Aristoflex HMB® and AVC®), cellulosic derivatives and natural

-7-
gums. Among useful cellulosic derivatives are sodium carboxymethylcellulose, hydroxy propyl methocellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, ethyl cellulose and hydroxymethyl cellulose. Natural gums suitable for the present invention include guar, xanthan, sderotium, carrageenan, pectin and combinations of these gums. Inorganics may also be utilized as thickeners, particularly clays such as bentonites and hectorites, fumed silicas, calcium carbonate and silicates such as magnesium aluminum silicate (Veegum®), Amounts of the thickener may range from 0.0001 to 10%, usually from 0.001 to 1%, optimally from 0.01 to 0.5% by weight of the composition.
Humectants may be employed in the present invention. These are generally polyhydric alcohol-type materials. Typical polyhydric alcohols include glycerol, propylene glycol, dipropylene glycol, polypropylene glycol, polyethylene glycol, sorbitol, hydroxypropyl sorbitol, hexylene glycol, 1,3-butylene glycol, isoprene glycol, 1,2,6-hexanetriol, ethoxylated glycerol, propoxylated glycerol and mixtures thereof. The amount of adjunct humectant may range anywhere from 0.5 to 50%, preferably between 1 and 15% by weight of the composition.
Compositions of the present invention may be in any form. These forms may include lotions, creams, roll-on formulations, sticks, mousses, aerosol and non-aerosoi sprays and fabric (e.g. nonwoven textile)-applied formulations. Particularly useful are nonwoven cloths of polypropylene or cotton/polyester impregnated with dihydroxyacetone and a cationic copolymer of the present invention.
Surfactants may also be present in compositions of the present invention. Total concentration of the surfactant when present may range from 0.1 to 30%, preferably from 0.1 to 15%, optimally from 0.5 to 2% by weight of the composition. The surfactant may be selected from the group consisting of anionic, nonionic, cationic and amphoteric actives. Particularly preferred nonionic surfactants are those with a C10-C20 fatty alcohol or acid hydrophobe condensed with from 2 to 100 moles of ethylene oxide or propylene oxide per mole of hydrophobe; C2-C10 alkyl phenols condensed with from 2 to 20 moles of alkylene oxide; mono- and di-fatty acid esters of ethylene glycol; fatty acid monoglyceride; sorbitan, mono- and di- C8-C20 fatty acids; and polyoxyethylene sorbitan

-8-
as well as combinations thereof. Alkyl polyglycosides and saccharide fatty amides (e.g. methyl gluconamides) and trialkylamine oxides are also suitable nonionic surfactants.
Preferred anionic surfactants include soap, alkyl ether sulfates and sulfonates, alkyl sulfates and sulfonates, alkylbenzene sulfonates, alkyl and dialkyl sulfosuccinates, C8-C20 acyl isethionates, C8-C20 alkyl ether phosphates, C8-C20 sarcosinates, C8-C20 acyl lactylates, sulfoacetates and combinations thereof.
Useful amphoteric surfactants include cocoamidopropyl betaine, C12-C20 trialkyl betaines, sodium lauroamphoacetate, and sodium laurodiamphoacetate.
Advantageously present may also be water-insoluble organic material in the form of polymeric porous spherical particles. By the term "porous" is meant an open or closed cell structure. Preferably the particles are not hollow beads. Average particle size may range from 0.1 to 100, preferably from 1 to 50, more preferably greater than 5 and especially from 5 to 15, optimally from 6 to 10 jim. Organic polymers or copolymers are the preferred materials and can be formed from monomers including the acid, salt or ester forms of acrylic acid and methacrylic acid, methylacrylate, ethylacrylate, ethylene, propylene, vinylidene chloride, acrylonitrile, maleic acid, vinyl pyrrolidone, styrene, butadiene and mixtures thereof. The polymers are especially useful in cross-linked form. Cells of the porous articles may be filled by a gas which can be air, nitrogen or a hydrocarbon. Oil Absorbance (castor oil) is a measure of porosity and in the preferred but not limiting embodiment may range from 90 to 500, preferably from 100 to 200, optimally from 120 to 180 ml/100 grams. Density of the particles in the preferred but not limiting embodiment may range from 0.08 to 0.55, preferably from 0.15 to 0.48 g/cm3
Illustrative porous polymers include polymethylmethacrylate and cross-linked polystyrene. Most preferred is polymethyl methacryJate available as Ganzpearl® GMP 820 available from Presperse, Inc., Piscataway, New Jersey, known also by its INCI name of Methyl Methacrylate Crosspolymer.
Amounts of the water-insoluble polymeric porous particles may range from 0.01 to 10%, preferably from 0.1 to 5%, optimally from 0.3 to 2% by weight of the composition.

-9-
Preservatives can desirably be incorporated into the personal care compositions of this invention to protect against the growth of potentially harmful microorganisms. Particularly preferred preservatives are phenoxyethanol, methyl paraben, propyl paraben, imidazolidinyl urea, dimethyloidimethylhydantoin, ethylenediaminetetraacetic acid salts (EDTA), sodium dehydroacetate, methylchloroisothiazolinone, methylisothiazolinone, iodopropynbutylcarbamate and benzyl alcohol. The preservatives should be selected having regard for the use of the composition and possible incompatibilities between the preservatives and other ingredients. Preservatives are preferably employed in amounts ranging from 0.01% to 2% by weight of the composition.
A variety of herbal extracts may optionally be included in compositions of this invention. The extracts may either be water soluble or water-insoluble carried in a solvent which respectively is hydrophilic or hydrophobic. Water and ethanol are the preferred extract solvents. Illustrative extracts include those from green tea., chamomile, licorice, aloe vera, grape seed, citrus unshui, willow bark, sage, thyme and rosemary.
Also included may be such materials as lipoic acid, retinoxytrimethylsilane (available from Clariant Corp. under the Silcare 1M-75 trademark), dehydroepiandrosterone (DHEA) and combinations thereof. Ceramides (including Ceramide 1, Ceramide 3, Ceramide 3B and Ceramide 6) as well as pseudoceramides may also be useful. Amounts of these materials may range from 0.000001 to 10%, preferably from 0.0001 to 1% by weight of the composition.
Colourants, opacifiers and abrasives may also be included in compositions of the present invention. Each of these substances may range from 0.05 to 5%, preferably between 0.1 and 3% by weight of the composition.
Still other suitable actives for skin compositions and use in the present invention include creatine, resveratrol, hyaluronic acid (particularly those of molecular weight of around 800), and combinations thereof. Amounts may range from 0.000001 to 5%, preferably from 0.001 to 1% by weight of the composition.

-10-
Compositions of the present invention may also contain vitamins. Illustrative water-soluble vitamins are niacinamide, vitamin B2, vitamin B6 vitamin C and biotin. Among the useful water-insoluble vitamins are vitamin A (retinol), vitamin A palmitate, ascorbyl tetraiso pa Imitate, vitamin E (tocopherol), vitamin E acetate and DL-panthenol. Total amount of vitamins when present in compositions according to the present invention may range from 0.001 to 10%, preferably from 0.01% to 1%, optimally from 0.1 to 0.5% by weight of the composition.
Desquamation agents are further optional components. Illustrative are the alpha-hydroxycarboxylic acids and beta-hydroxycarboxylic acids and salts of these acids. Among the former are salts of glycolic acid, lactic acid and malic acid. Salicylic acid is representative of the beta-hydroxycarboxylic acids. Amounts of these materials when present may range from 0.1 to 15% by weight of the composition.
Except in the operating and comparative examples, or where otherwise explicitly indicated, all numbers in this description indicating amounts of material ought to be understood as modified by the word "about".
The term "comprising" is meant not to be limiting to any subsequently stated elements but rather to encompass non-specified elements of major or minor functional importance. In other words the listed steps, elements or options need not be exhaustive. Whenever the words "including" or "having" are used, these terms are meant to be equivalent to "comprising" as defined above.
All documents referred to herein, including all patents, patent applications, and printed publications, are hereby incorporated by reference in their entirety in this disclosure.
The following examples will more fully illustrate the embodiments of this invention. All parts, percentages and proportions referred to herein and in the appended claims are by weight unless otherwise illustrated.

EXAMPLE 1-8
A series of typical body lotions according to the present invention are outlined in table I
below.

TABLE I
Component Example (Weight %)
1 2 3 4 5 6 7 8
Glycerin 12.00 10.00 10.00 12.00 12.00 12.00 8.00 8.00
Dihydroxyacetone 2.50 3.00 5.00 3.50 3.50 0.50 0.50 5.00
Isopropyl pa Imitate 2.25 2.25 2.25 2.25 2.25 2.25 2.25 2.25
Stearic acid 2.00 2.00 2.00 2.00 2.00 2.00 2.00 2.00
Thickening agent 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50
Glycol stearate/stearamide AMP 1.20 1.20 1.20 1.20 1.20 1.20 1.20 1.20
Dimethicone {DC 200) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Cationic copolymer 7688 MP 1.00 0.50 0.50 1.50 2.50 1.00 1.00 5.00
PEG-100stearate 1.00 0.50 0.50 1.00 1.00 0.75 1.00 1.00
Glycerol stearate 0.55 0.50 0.50 0.80 0.55 0.55 0.30 0.30
Cyclopentasiloxane/dimeth iconol (DC 1501) 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50
Phenoxyethanol 0.40 0.40 0.40 0.40 0.40 0.40 0.40 0.40
Cetyl alcohol 0.30 0.30 0.30 0.30 0.30 0.30 0.30 0.30
Methyl paraben 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20
Propyl paraben 0.10 0.10 0.10 0.10 0.10 0.10 0.10 0.10
Water balance balance balance balance balance balance balance balance
EXAMPLE 9
A set of experiments are here reported comparing the cationic copolymer of the present
invention with related quaternary ammonium materials.
A base formula was utilized and different quaternary ammonium materials were added. The base is outlined in table II below.
TABLE II Base Formula

Component Weight %
Glycerin 12.0
Dihydroxyacetone 2.5
Isopropyl palmitate 2.3
Colour enhancing agent *
Stearic acid 2.0

Glycol stearate/stearamideAMP 1.2
Silicones 1.5
PEG-100stearate 1.0
Glycerol stearate 0.5
Phenoxyethanol 0.4
Fragrance 0.4
Cetyl alcohol 0.3
Erythrulose 0.3
Methyl parataen 0.2
Colourants 0.2
Propyl paraben 0.1
Citric acid 0.1
Tetrasodium EDTA (39% Active) 0.1
Gel thickener 0.1
Deionized water Balance to W0
Four samples were prepared with different quaternary ammonium or control polymers in the base formula. Each of the samples was applied onto a forearm area of a subject at 20 mg/cm2 dosage. The sample was allowed to dry on the skin for 3 minutes. Thereafter, the skin was rinsed under running water for 2 minutes.
Prior to treatment and eight hours subsequent thereto, the area of treatment was observed for colouration. Measurements were taken with a Hunter Lab Spectra Colorimeter, with values reported for L, a* and b*. Results are detailed in table II!.
TABLE III

Sample Colour Enhancing Agent L a* b* Delta E Observations
- initial Skin Value 67.47 7.94 14.74 ~
1 SimulgelNS(1.5%)(i) 66.41 8.05 15.00 1.09 Streaking
2 Distearyl Dimonium Chloride (0.2%) 64.92 8.51 16.51 3.16 Some streaking
3 Simulgel 7688 MP Cationic Polymer (1.5%)(ii) 60.41 9.68 19.22 8,62 No streaking
4 Distearyl Dimonium Chloride (0.2%) and Simulgel 7688 MP Cationic Polymer (1.5%) 59.62 10.04 19.19 9.68 No streaking
(i) Simulgel NS is a Seppic trademark for hydroxyethylacrylate/sodium
acrylodimethyltaurate polymer. (ii) Simulgel 7688 MP is a Seppic trademark for acrylamide/acryloylethyl
trimethylammonium chloride/tris(hydroxymethyl)acrylamidomethane copolymer.

Sample 1, which is a standard control, exhibited considerable loss of the tanning effect at the eight hour mark. There was also streaking of the tan. Sample 2 utilized a monomeric quaternary ammonium compound which is distearyl dimonium chloride. Colour intensity loss (delta E) improved and less streaking was produced than the control. Sample 3 utilizing a crosslinked cationic copolymer per the present invention resulted in a significant enhancement of the tanning effect and no streaking was observed. An even further enhancement was seen in Sample 4. In this experiment the crosslinked cationic copolymer of the present invention was combined with a monomeric quaternary ammonium compound (distearyl dimonium chloride). Tanning effect retention was increased further and streaking was not observed. Based on these results, it is evident that the crosslinked cationic copolymer of the present invention operates as a colour enhancing agent.
Further experiments were conducted to evaluate effects of different cationic polymers. These experiments were done several months subsequent to those under table 111 and, therefore, exhibited slightly different initial skin values. In all other respects, the experiments were done in accordance with those for which the table III results were obtained.
TABLE IV

Sample Colour Enhancing Agent L a* b* Delta E Observations
- Initial Skin Value 67.58 7.84 14.70 ~
5 SimulgelNS(1.5%)(i) 66.59 8.10 15.08 1.09 Streaking
6 Aristoflex® AVC(1.5%) (ii) 66.53 8.03 15.14 1.15 Streaking
7 5epigel®305(1.5%)(iii) 66.61 8.15 15.02 1.06 Streaking
S Merquat® 5(1.5) (iv) 65.07 8.42 16.44 3.08 Some streaking
(i) Simulgel NS is a Seppic trademark for hydroxyethylacrylate/sodium
acrylodimethyltaurate polymer. (ii) Aristoflex® AVC is a Clariant Corp. trademark for acryloy! dimethyltaurate/vinyl
pyrrolidone copolymer. (iii) Sepigel® 305 is a Seppic trademark for polyacrylamide. (iv) Merquat® 5 is a Nalco Corp. trademark for acrylamide/methacryloyloxyethyl trimethyl
ammonium methylsulfate copolymer.

Table IV employs Sample 5 (equivalent to Sample 1) as a standard control. This material exhibited considerable loss of the tanning effect at the eight hour mark. There was also streaking of the tan. Sample 7 is a non-cationic polymer based on acrylamide monomer units. The relatively low delta E value indicates considerable loss of tan colouration upon rinse. Sample 8 is a cationic copolymer but differs from that utilized in Sample 3 by not having a crosslinking agent (i.e. tris(hydroxymethyl)acrylamidomethane). Sample 8 had a delta E of 3.08 which was much better than those of the nonionic polymers/copolymers in formulas represented by Samples 1, 5, 6 and 7. Moreover, there was also improvement in reducing streaking. Best performance was exhibited by Sample 3 which is a formula according to the present invention utilizing a cationic polymer. Sample 3 imparted to skin a significant enhancement of the tanning effect and no streaking was observed.
EXAMPLE 10
Experiments with but one exception identical to those of example 9 were conducted and reported hereunder. The same base formula and samples were utilized to evaluate differences in intensity of colour prior to any rinse.
Table V and VI record two sets of colour enhancement measurements {delta E), the latter set being performed several months subsequent to the former. In all other respects, the experiments of tables V and VI were done identically.
TABLE V

Sample Colour Enhancing Agent L a* b* Delta E
- Initial Skin Value 67.47 7.94 14.74 ~
1 SimulgelNS(1.5%)(i) 65.39 8.31 15.62 2.29
2 Distearyl Dimonium Chloride (0.2%) 63.51 8.87 17.71 5.04
3 Simulgel 7688 MP Cationic Polymer (1.5%)(ii) 59.83 10.02 20.07 9.62
4 Distearyl Dimonium Chloride (0.2%)
and
Simulgel 7688 MP Cationic Polymer
(1.5%) 58.41 10.34 20.21 10.85
(i) Simulgel NS is a Seppic trademark for hydroxyethylacrylate/sodium
acrylodimethyltaurate polymer. (ii) Simulgel 7688 MP is a Seppic trademark for acrylamide/acryloylethyl
tri methyl ammonium chloride/tris(hydroxymethyl)acrylamidomethane copolymer.

TABLE VI

Sample Colour Enhancing Agent L a* b* Delta E
- Initial Skin Value 67.14 7.89 14.78 ~
5 Simulgel NS(1.5%)(i) 65.41 8.35 15.64 1.99
6 Aristoflex® AVC(1.5%) (if) 65.18 833 15.60 2.10
7 Sepigel®305(1.5%)(iii) 65.27 8.29 15.70 2.03
8 Merquat® 5{1.5)(iv) 62.98 8.88 17.75 5.19
(i) Simulgel N5 is a Seppic trademark for hydroxyethylacrylate/sodium
acrylodimethyltaurate polymer. (ii) Aristoflex® AVC is a Clariant Corp. trademark for acryloyl dimethyltaurate/vinyl
pyrrolidone copolymer. (iii) Sepigel® 305 is a Seppic trademark for polyacrylamide. (iv) Merquat® 5 is a Nalco Corp. trademark for acrylamide/methacryloyloxyethyl trimethyl
ammonium methylsulfate copolymer.
Sample 3 represents the present invention. Intensity of colour change reached 9.62 (delta E). Addition of distearyl dimonium chloride (0.2%) to the Simulgel 7688 cationic polymer (1.5%) resulted in a further colouration enhancement to 10.85 (delta E) (see Sample 4). By comparison. Samples 5 and 6 representing nonionic acrylo type polymers managed only to increase the delta E to values of 1.99 and 2.10, respectively. Merquat® 5 which is a non-crosslinked cationic polyacrylamide and methacryloyl type polymer had an appreciable colour intensity enhancement. Sample 8 exhibited a 5.19 delta E. However, the crosslinked cationic copolymer of Sample 3 exhibited a significantly higher delta E value.

CLAIMS:
1. A cosmetic product for imparting a glow or sunless tan to skin comprising:
(i) from 0.1 to 20% by weight of a tanning agent which is reactive with skin to
produce a tan colour; (ii) from 0.1 to 20% by weight of a colour enhancing agent which is a
crosslinked cationic copolymer comprising monomer units of
methacryloylethyl tri(C1-C3 alkyl) ammonium salt or acryloylethyl tri(C1-C3
alky!) ammonium salf and (iii) a cosmeticafly acceptable carrier,
wherein the crosslinked cationic copolymer is aorylamide/acryloylethyl trimethylammoniumchloride/tris(hydroxymethyl-acrylamtdomethane) copolymer.
2. A product according to claim 1 wherein the tanning agent is dihydroxyacetone.
3. A product according to any one of the preceding claims wherein the crosslinked cationic copolymer is present in an amount from 0.5 to 10% by weight of the composition.
4. A product according to any one of the preceding claims wherein the tanning agent is present in an amount from 0.5 to 10% by weight of the composition.
5. A product according to any one of the preceding claims further comprising from 0.01 to 5% by weight of a monomeric quaternary ammonium salt.
6. A product according to claim 5 wherein the monomeric quaternary ammonium salt is a di(C12-C22) fatty alkyl substituted ammonium salt

7. A product according to claim 5 wherein the monomeric quaternary ammonium salt is distearyl dimonium chloride.

Documents

Application Documents

# Name Date
1 1752-MUMNP-2010-CORRESPONDENCE(13-12-2012).pdf 2012-12-13
1 1752-MUMNP-2010-RELEVANT DOCUMENTS [15-09-2022(online)].pdf 2022-09-15
2 1752-MUMNP-2010-FORM 3 (10-12-2013).pdf 2013-12-10
2 1752-MUMNP-2010-RELEVANT DOCUMENTS [09-09-2021(online)].pdf 2021-09-09
3 1752-MUMNP-2010-REPLY TO EXAMINATION REPORT(17-10-2014).pdf 2014-10-17
3 1752-MUMNP-2009-FORM 3(25-4-2015).pdf 2018-08-10
4 1752-MUMNP-2010-OTHER DOCUMENT(17-10-2014).pdf 2014-10-17
4 1752-mumnp-2010-assignment.pdf 2018-08-10
5 1752-MUMNP-2010-FORM PCT-ISA-210(17-10-2014).pdf 2014-10-17
6 1752-MUMNP-2010-FORM PCT-IPEA-409(17-10-2014).pdf 2014-10-17
6 1752-mumnp-2010-claims.pdf 2018-08-10
7 1752-MUMNP-2010-FORM 3(10-11-2014).pdf 2014-11-10
7 1752-MUMNP-2010-CORRESPONDENCE(3-7-2015).pdf 2018-08-10
8 1752-MUMNP-2010_EXAMREPORT.pdf 2018-08-10
8 1752-MUMNP-2010-CORRESPONDENCE(8-11-2011).pdf 2018-08-10
9 1752-MUMNP-2010-Correspondence-070915.pdf 2018-08-10
9 1752-mumnp-2010-wo international publication report a1.pdf 2018-08-10
10 1752-MUMNP-2010-Correspondence-080116.pdf 2018-08-10
10 1752-MUMNP-2010-OTHERS-161214.pdf 2018-08-10
11 1752-MUMNP-2010-Correspondence-090216.pdf 2018-08-10
11 1752-MUMNP-2010-GENERAL POWER OF ATTORNEY(3-11-2010).pdf 2018-08-10
12 1752-MUMNP-2010-Correspondence-161214.pdf 2018-08-10
12 1752-mumnp-2010-form pct-isa-210.pdf 2018-08-10
13 1752-mumnp-2010-correspondence.pdf 2018-08-10
13 1752-mumnp-2010-form pct-ipea-416.pdf 2018-08-10
14 1752-MUMNP-2010-CORRESPONDENCEY(3-11-2010).pdf 2018-08-10
14 1752-mumnp-2010-form pct-ipea-409.pdf 2018-08-10
15 1752-mumnp-2010-description(complete).pdf 2018-08-10
15 1752-mumnp-2010-form 5.pdf 2018-08-10
16 1752-mumnp-2010-form 3.pdf 2018-08-10
16 1752-MUMNP-2010-Examination Report Reply Recieved-271114.pdf 2018-08-10
17 1752-MUMNP-2010-Form 3-190316.pdf 2018-08-10
17 1752-mumnp-2010-form 1.pdf 2018-08-10
18 1752-MUMNP-2010-FORM 13(10-2-2012).pdf 2018-08-10
18 1752-MUMNP-2010-Form 3-081015.pdf 2018-08-10
19 1752-MUMNP-2010-FORM 18(8-11-2011).pdf 2018-08-10
19 1752-MUMNP-2010-FORM 3(8-8-2012).pdf 2018-08-10
20 1752-mumnp-2010-form 2(title page).pdf 2018-08-10
20 1752-MUMNP-2010-FORM 3(23-1-2013).pdf 2018-08-10
21 1752-MUMNP-2010-FORM 3(22-6-2013).pdf 2018-08-10
22 1752-mumnp-2010-form 2.pdf 2018-08-10
22 1752-MUMNP-2010-FORM 3(22-5-2014).pdf 2018-08-10
23 1752-MUMNP-2010-FORM 3(15-2-2012).pdf 2018-08-10
23 1752-MUMNP-2010-FORM 3(12-8-2011).pdf 2018-08-10
24 1752-MUMNP-2010-FORM 3(15-2-2011).pdf 2018-08-10
25 1752-MUMNP-2010-FORM 3(12-8-2011).pdf 2018-08-10
25 1752-MUMNP-2010-FORM 3(15-2-2012).pdf 2018-08-10
26 1752-mumnp-2010-form 2.pdf 2018-08-10
26 1752-MUMNP-2010-FORM 3(22-5-2014).pdf 2018-08-10
27 1752-MUMNP-2010-FORM 3(22-6-2013).pdf 2018-08-10
28 1752-mumnp-2010-form 2(title page).pdf 2018-08-10
28 1752-MUMNP-2010-FORM 3(23-1-2013).pdf 2018-08-10
29 1752-MUMNP-2010-FORM 18(8-11-2011).pdf 2018-08-10
29 1752-MUMNP-2010-FORM 3(8-8-2012).pdf 2018-08-10
30 1752-MUMNP-2010-FORM 13(10-2-2012).pdf 2018-08-10
30 1752-MUMNP-2010-Form 3-081015.pdf 2018-08-10
31 1752-mumnp-2010-form 1.pdf 2018-08-10
31 1752-MUMNP-2010-Form 3-190316.pdf 2018-08-10
32 1752-MUMNP-2010-Examination Report Reply Recieved-271114.pdf 2018-08-10
32 1752-mumnp-2010-form 3.pdf 2018-08-10
33 1752-mumnp-2010-description(complete).pdf 2018-08-10
33 1752-mumnp-2010-form 5.pdf 2018-08-10
34 1752-MUMNP-2010-CORRESPONDENCEY(3-11-2010).pdf 2018-08-10
34 1752-mumnp-2010-form pct-ipea-409.pdf 2018-08-10
35 1752-mumnp-2010-form pct-ipea-416.pdf 2018-08-10
35 1752-mumnp-2010-correspondence.pdf 2018-08-10
36 1752-MUMNP-2010-Correspondence-161214.pdf 2018-08-10
36 1752-mumnp-2010-form pct-isa-210.pdf 2018-08-10
37 1752-MUMNP-2010-Correspondence-090216.pdf 2018-08-10
37 1752-MUMNP-2010-GENERAL POWER OF ATTORNEY(3-11-2010).pdf 2018-08-10
38 1752-MUMNP-2010-Correspondence-080116.pdf 2018-08-10
38 1752-MUMNP-2010-OTHERS-161214.pdf 2018-08-10
39 1752-MUMNP-2010-Correspondence-070915.pdf 2018-08-10
39 1752-mumnp-2010-wo international publication report a1.pdf 2018-08-10
40 1752-MUMNP-2010-CORRESPONDENCE(8-11-2011).pdf 2018-08-10
40 1752-MUMNP-2010_EXAMREPORT.pdf 2018-08-10
41 1752-MUMNP-2010-FORM 3(10-11-2014).pdf 2014-11-10
41 1752-MUMNP-2010-CORRESPONDENCE(3-7-2015).pdf 2018-08-10
42 1752-MUMNP-2010-FORM PCT-IPEA-409(17-10-2014).pdf 2014-10-17
42 1752-mumnp-2010-claims.pdf 2018-08-10
43 1752-MUMNP-2010-FORM PCT-ISA-210(17-10-2014).pdf 2014-10-17
44 1752-MUMNP-2010-OTHER DOCUMENT(17-10-2014).pdf 2014-10-17
44 1752-mumnp-2010-assignment.pdf 2018-08-10
45 1752-MUMNP-2010-REPLY TO EXAMINATION REPORT(17-10-2014).pdf 2014-10-17
45 1752-MUMNP-2009-FORM 3(25-4-2015).pdf 2018-08-10
46 1752-MUMNP-2010-FORM 3 (10-12-2013).pdf 2013-12-10
46 1752-MUMNP-2010-RELEVANT DOCUMENTS [09-09-2021(online)].pdf 2021-09-09
47 1752-MUMNP-2010-CORRESPONDENCE(13-12-2012).pdf 2012-12-13
47 1752-MUMNP-2010-RELEVANT DOCUMENTS [15-09-2022(online)].pdf 2022-09-15

ERegister / Renewals

3rd: 06 Aug 2016

From 29/01/2011 - To 29/01/2012

4th: 06 Aug 2016

From 29/01/2012 - To 29/01/2013

5th: 06 Aug 2016

From 29/01/2013 - To 29/01/2014

6th: 06 Aug 2016

From 29/01/2014 - To 29/01/2015

7th: 06 Aug 2016

From 29/01/2015 - To 29/01/2016

8th: 06 Aug 2016

From 29/01/2016 - To 29/01/2017

9th: 27 Dec 2016

From 29/01/2017 - To 29/01/2018

10th: 29 Dec 2017

From 29/01/2018 - To 29/01/2019

11th: 28 Dec 2018

From 29/01/2019 - To 29/01/2020

12th: 09 Dec 2019

From 29/01/2020 - To 29/01/2021